Taipei, Taiwan

Chung-Kuang Lu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kaohsiung Medical University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung-Kuang Lu. Retrieved from https://idiyas.com/inventor/chung-kuang-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chung-Kuang Lu in Anticancer Research

Introduction

Chung-Kuang Lu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of anticancer compositions. His work focuses on innovative solutions for inhibiting liver tumors, showcasing his dedication to advancing healthcare.

Latest Patents

Chung-Kuang Lu holds a patent for an anticancer composition and its use. The patent describes a composition designed to inhibit liver tumors in organisms. This composition includes an activator known as 1,2,3,4,6-penta-O-galloyl-Beta-D-glucopyranoside (PGG), which is extracted from sources such as Pall. and Galla Chinesis. This innovative approach highlights the potential of natural compounds in cancer treatment.

Career Highlights

Chung-Kuang Lu is affiliated with Kaohsiung Medical University, where he continues to engage in groundbreaking research. His work not only contributes to scientific knowledge but also aims to improve patient outcomes through innovative therapeutic strategies.

Collaborations

Chung-Kuang Lu collaborates with esteemed colleagues, including Chia-Hung Yen and Yi-Ming Chen. These partnerships enhance the research efforts and foster a collaborative environment for innovation in cancer research.

Conclusion

Chung-Kuang Lu's contributions to anticancer research exemplify the impact of innovative thinking in medicine. His patent for an anticancer composition represents a significant step forward in the fight against liver tumors. Through his work at Kaohsiung Medical University and collaborations with fellow researchers, he continues to pave the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…